Investor Alert

Gamida Cell Ltd.



After Hours

 --Quotes are delayed by 20 min

Dec 1, 2023, 6:06 p.m.





+0.0090 +2.73%


Volume 46,513

Quotes are delayed by 20 min


Today's close

$ 0.31

$ 0.33


+0.02 +6.45%

Day low

Day high




52 week low

52 week high




Michele I. Korfin

Presently, Michele I. Korfin occupies the position of Chief Operating & Commercial Officer at Gamida Cell Ltd. and Secretary & Trustee at BioNJ, Inc. She is also on the board of Organogenesis Holdings, Inc.

In her past career Ms. Korfin occupied the position of Chief Operating Officer at Tyme Technologies, Inc., Head-Oncology Sales Force at Celgene Corp. and Vice President-Market Access at Kite Pharma, Inc.

She received an MBA from Harvard Business School and an undergraduate degree from Rutgers State University of New Jersey.


Date Shares Transaction Value
02/08/2023 92,990   Award at $0 per share. 0
01/28/2022 63,800   Award at $0 per share. 0

Officers and Executives

Ms. Abigail L. Jenkins
President, Chief Executive Officer & Director
Ms. Michele I. Korfin
Chief Operating & Commercial Officer
Ms. Mary Theresa Coelho
Chief Financial & Accounting Officer
Dr. Yona Geffen
Vice President-Research & Development
Dr. Ronit Simantov
Chief Medical & Scientific Officer
Mr. Vladimir Melnikov
Senior VP-Global Operations & Manufacturing
Mr. Joshua F. Patterson
Chief Compliance Officer & General Counsel
Mr. Yisrael Gewirtz
Internal Auditor
Ms. Heather DiVecchia
Director-Investor Relations & Communications
Ms. Shawn Cline Tomasello
Mr. Stephen T. Wills
Independent Director
Dr. Ivan M. Borrello
Independent Director
Dr. Julian Adams
Independent Director
Mr. Kenneth I. Moch
Independent Non-Executive Director
Link to MarketWatch's Slice.